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Background and objectives: Heart rate variability (HRV) has been intensively studied 
as a promising biological marker of major depressive disorder (MDD). Our previous study 
confirmed that autonomic activity and reactivity in depression revealed by HRV during 
rest and mental task (MT) conditions can be used as diagnostic measures and in clinical 
evaluation. In this study, logistic regression analysis (LRA) was utilized for the classifica-
tion and prediction of MDD based on HRV data obtained in an MT paradigm.
Methods: Power spectral analysis of HRV on R–R intervals before, during, and after an 
MT (random number generation) was performed in 44 drug-naïve patients with MDD and 
47 healthy control subjects at Department of Psychiatry in Shizuoka Saiseikai General 
Hospital. Logit scores of LRA determined by HRV indices and heart rates discriminated 
patients with MDD from healthy subjects. The high frequency (HF) component of HRV 
and the ratio of the low frequency (LF) component to the HF component (LF/HF) corre-
spond to parasympathetic and sympathovagal balance, respectively.
results: The LRA achieved a sensitivity and specificity of 80.0 and 79.0%, respectively, 
at an optimum cutoff logit score (0.28). Misclassifications occurred only when the logit 
score was close to the cutoff score. Logit scores also correlated significantly with sub-
jective self-rating depression scale scores (p < 0.05).
conclusion: HRV indices recorded during a MT may be an objective tool for screening 
patients with MDD in psychiatric practice. The proposed method appears promising for 
not only objective and rapid MDD screening but also evaluation of its severity.
Keywords: heart rate variability, major depressive disorder, self-rating depression scale, logistic regression 
analysis, autonomic activity
FigUre 1 | a schematic diagram of heart rate variability (hrV) monitoring. Electrocardiograms (ECGs) were recorded before, during, and after a mental task (MT).
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inTrODUcTiOn
Major depressive disorder (MDD) is a critical public health 
concern, with an estimated 350 million people having this 
disease worldwide (1). Therefore, rapid and accurate detection 
of patients with MDD during the early stages can facilitate the 
decision-making process of psychiatric clinicians in the mental 
health treatment of patients. Unlike other areas of medicine, 
objective diagnostic biomarkers for psychiatric diseases are not 
readily available (2, 3). Psychiatric clinicians diagnose outpatients 
subjectively based on clinical interview and diagnostic criteria. 
Thus, the diagnosis of MDD tends to depend on the knowledge 
and experience of the clinician (4). In this study, we propose a 
novel, non-invasive, objective, and physiological method for 
screening outpatients with MDD that uses quantitative estimates 
of altered autonomic nervous system activity and reactivity based 
on heart rate variability (HRV) indices via logistic regression 
analysis (LRA).
Heart rate variability, which refers to beat-to-beat alterations 
in the heart rate (HR), can be used to assess autonomic nervous 
system function (5). Low frequency (LF: 0.04–0.15  Hz), high 
frequency (HF: 0.15–0.4 Hz), and LF/HF HRV indices provide 
quantitative estimates of sympathetic and parasympathetic 
activities (6). Changes in HRV have been found in various dis-
orders presenting both somatic and psychological symptoms, 
including eating disorder, pain, anxiety, stress disorder, and 
depression (7–9). Although HRV changes appear non-specific, 
frequent comorbidity of these disorders may underlie the 
prevalence. Recent studies have shown a strong association 
between MDD and HRV abnormalities (10–12). A recent 
review investigated the impact of depression on HRV indices 
in patients with MDD without cardiovascular disease (13). 
High HR and LF/HF and low HF among patients with MDD 
reflect a baseline shift of autonomic balance toward sympathetic 
activation (14–16).
In addition to altered autonomic baseline activity, we further 
assessed the reactivity of HRV measurements during rest and 
mental task (MT) conditions in patients with MDD and healthy 
control subjects (17, 18). We found that both HRV at rest and its 
response to MT conditions were different in patients with MDD. 
Specifically, HF, LF/HF, and HR were less reactive in patients with 
MDD compared with healthy subjects during the MT condition. 
Differences in the reactive of HRV indices during rest following 
the MT condition were also observed. These multiple autonomic 
alterations in MDD are possibly related to disturbances in arousal 
control. These findings suggest that HRV indices may be a useful 
screening tool for MDD in clinical practice. One such method 
involves the use of HF, LF/HF, and HR before, during, and after 
an MT in LRA.
In the present study, a prediction model for binary classifica-
tion of multidimensional data (i.e., HF, LF/HF, and HR indices) 
was constructed using multiple LRAs. LRA, which is a probabil-
istic statistical classification model, is a simple but powerful linear 
algorithm for analyzing multidimensional data and generating 
predictions of clinical results (19). The aim of this study was to 
evaluate the efficacy of a proposed screening method for risk 
stratification of patients with MDD in clinical settings.
MaTerials anD MeThODs
Participants
We tested this method with clinical data from 44 patients, 
thereby performing a qualitative assessment of the proposed 
screening method based on LRA for risk stratification of 
patients with MDD. The patients (43 ±  12  years old; 23 men 
and 21 women) from Shizuoka Saiseikai General Hospital were 
drug-naïve patients and had a diagnosis of MDD according to 
the Diagnostic and Statistical Manual of Mental Disorders, 4th 
edition (DSM-IV) criteria published by the American Psychiatric 
Association. Forty-seven age- and sex-matched healthy control 
subjects (41 ±  12  years old; 21 men and 26 women) who had 
never been diagnosed with cardiac, neurological, or psychiatric 
disorders were also included. There was no difference in the pro-
portion of tobacco users between patients and healthy subjects. 
FigUre 2 | heart rate variability (hrV) and heart rate (hr) indices before, during, and after a mental task (MT) in a representative healthy control 
subject (left panels) and a patient with major depressive disorder (MDD) (right panels). The low frequency to high frequency ratio (LF/HF) (sympathetic 
index) and HR increased and HF (parasympathetic index) decreased during the MT condition in healthy control subjects, but not in patients with MDD.
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Participants were instructed not to consume alcohol or coffee 
for 24 h prior to the study and not to consume tobacco on the 
day of the study. The Zung’s self-rating depression scale (SDS) 
score was used to assess the severity of symptomatology for both 
groups (20). This study was approved by the Ethics Committee 
of Shizuoka Saiseikai General Hospital. All subjects provided 
written informed consent.
study Protocol
The study protocol has previously been described (18). Briefly, 
each subject was seated in a chair with electrodes attached to 
their chest (Figure 1). Electrocardiograms (ECGs) were recorded 
before, during, and after the MT. Prior to the MT, subjects were 
instructed to relax for 100 s. Following this rest period, subjects 
completed random number generation for 100 s as the MT. During 
the MT, subjects were instructed to verbalize single-digit numbers 
(0–9) in a random order at a rate of 1 Hz with the assistance of a 
metronome. Following the MT, subjects were instructed to relax 
for 120 s. ECG signals were transferred to a computer via an A/D 
converter for offline analysis. Heartbeat intervals and HR were 
derived from R peak intervals. Power spectra of the time series of 
the heartbeat intervals were detected every 2 s for the preceding 
30 s data using a maximum entropy method with the MemCalc 
software (GMS, Tokyo, Japan). To avoid the influence of preced-
ing states, HF, LF/HF, and HR were averaged in the interim from 
30 to 60 s after the onset of each new state.
FigUre 3 | receiver operating characteristic (rOc) curve to 
determine the optimum cutoff point for classifying the patients 
with MDD and healthy subjects. According to the ROC, the area 
under the curve for this screening test was 0.891 (95% confidence 
interval, 0.828–0.954); the sensitivity of 80.0% and specificity of 79.0% 
were obtained from the optimum cutoff point of 0.28.
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lra Development Using Multivariate Data
Logistic regression analysis, which is a probabilistic statistical 
classification model, is a simple but powerful linear algorithm 
for analyzing multidimensional data and generating predictions 
of clinical outcomes. Multivariate selection is an important step 
in the development of a multivariate model that can effectively 
separate patients with MDD from the healthy control subjects. 
In the present study, we included nine HRV and HR indices in 
the LRA: HFbeforeMT, HFMT, HFafterMT, LF/HFbeforeMT, LF/HFMT, LF/
HFafterMT, HRbeforeMT, HRMT, and HRafterMT.
We defined the above selected nine variables as x1−x9 in 
a nine-dimensional vector X =  (x1, x2, …, x9). LRA is a linear 
discriminative approach that attempts to optimize a logistic 
sigmoid function to calculate the probability p that vector X is 
representative of patients with MDD. The present study used 
binary classification; therefore, the probability of healthy control 
subjects is 1 − p. Thus, the LRA is expressed as follows:
 log p
p
b b x b x b x
1 0 1 1 2 2 9 9−





 = + + + +…  (1)
where log p
p1−





  is the predicted logit score, b0 is a constant, 
and b1, b2, …, b9 are regression coefficients estimated by maxi-
mum likelihood criterion. Probability p is written as the logistic 
sigmoid function:
 p
e b b x b x b x
=
+ − + + + +
1
1 0 1 1 2 2 9 9( )
 (2)
statistical analysis
We evaluated the ability of the LRA to discriminate patients with 
MDD by calculating the sensitivity, specificity, positive predictive 
value (PPV), and negative predictive value (NPV). The perfor-
mance of the LRA was evaluated using Nagelkerke’s R2 and Cox 
and Snell’s R2 tests (21). Moreover, to find the optimal cutoff point 
with the highest sensitivity and specificity of LRA, a receiver oper-
ating characteristic (ROC) curve was adopted. The area under the 
curve (AUC) of the ROC is considered an effective measure of the 
performance of a diagnostic test, with results ranging from 0.5 
to 1.0, where larger values are indicative of better performance 
(22). The HRV and HR indices were compared between the 
classified MDD group and the healthy group via Student’s t-test. 
A p-value of less than 0.05 was considered to indicate statistical 
significance. The LRA and ROC were performed using SPSS 23.0 
(IBM, Armonk, NY, USA).
resUlTs
Sample data from a patient with MDD and a healthy control 
subject are shown in Figure 2. In healthy control subjects, the LF/
HF and HR increase, and HF decreases during the MT condition 
and return to baseline levels following the MT. In contrast, these 
changes are not observed in patients with MDD.
To discriminate patients with MDD from healthy control 
subjects in our dataset, the logistic sigmoid function log p
p1−





  
was calculated from the HRV and HR variables with the following 
estimated regression coefficients:
log . . .
.
p
p1
5 062 0 201 0 053
0 086
−





 = − + −
−
HR HR
HR
beforeMT MT
afterMT beforeMT MT
afterMT be
HF HF
HF LF HF
− +
+ +
0 019 0 012
0 007 0 094
. .
. . / foreMT
MT afterMTLF HF LF HF− +0 087 0 312. / . /
 (3)
The derived logistic sigmoid function log p
p1−





  was sta-
tistically significant (p <  0.001). The Nagelkerke’s R2 and Cox 
and Snell’s R2 values were 0.614 and 0.461, respectively, which 
indicate that the derived logistic sigmoid function was useful 
in discriminating patients with MDD. The ROC analysis was 
performed to find the optimal cutoff point of predicted LRA 
logit score to discriminate the patients with MDD from healthy 
subjects (Figure  3). According to the ROC, the AUC for this 
screening test was 0.891 (95% confidence interval, 0.828–0.954), 
which indicated that the LRA was able to significantly distin-
guish between patients with MDD and the healthy group. In 
addition, a sensitivity of 80.0% and specificity of 79.0% were 
obtained from an optimum cutoff point of LRA logit score (0.28). 
Furthermore, a scatter plot was used to compare the results of 
our HRV-based objective screening method with subjective SDS 
scores (Figure 4). With this cutoff point, a total of 35 patients 
with MDD were predicted as patients with MDD by the LRA; 
9 patients with MDD were misdiagnosed as healthy. Similarly, 
a total of 37 healthy control subjects were predicted as healthy 
FigUre 4 | With the cutoff point of 0.28, a total of 35 patients with major depressive disorder (MDD) (blue triangles) were predicted as patients with 
MDD by the logistic regression analysis (lra); 9 patients (red triangles) with MDD were misdiagnosed as healthy. Similarly, a total of 37 healthy control 
subjects (green circles) were predicted as healthy control subjects; 10 healthy control subjects (red circles) were misdiagnosed as patients with MDD. The gray area 
highlights the boundary region between patients with MDD and healthy control subjects, which demonstrates that the 9 false negatives and 10 false positives occur 
at the boundary region.
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control subjects; 10 healthy control subjects were misdiagnosed 
as patients with MDD. The corresponding PPV and NPV of the 
LRA were 78.0 and 80.4%, respectively. The gray area highlights 
the boundary region between patients with MDD and healthy 
control subjects, which demonstrates that the 9 false negatives 
and 10 false positives occur at the boundary region. In contrast, 
the sensitivity, specificity, PPV, and NPV were 72.0, 85.1, 82.0, 
and 76.9%, respectively, for the SDS score using a cutoff of 50. 
Thus, our HRV-based objective method using LRA significantly 
improved sensitivity and NPV compared with the SDS score 
alone. Logit scores also correlated significantly with subjective 
SDS score (r = 0.4, p < 0.05). Moreover, the HRV and HR indices 
were compared with the MDD and healthy groups. Figure 5A 
shows that the HR of before MT differed significantly among 
MDD and healthy groups (p <  0.05), whereas no significant 
difference are found on MT and after MT conditions. Figure 5B 
shows that the HF of before MT and after MT conditions differed 
significantly among MDD and healthy groups (p <  0.05), but 
no difference was present on MT conditions. Figure 5C shows 
that the LF/HF of before MT and after MT conditions differed 
significantly among MDD and healthy groups (p <  0.05), but 
no difference on MT conditions. Table  1 summarizes a more 
detailed comparison between our HRV-based objective method 
and patient-reported subjective SDS scores in part. In order to 
better understand the data, we sorted the table in descending 
order on logit scores. We found that the misclassified individu-
als gathered at close to the cutoff on both the patient-reported 
subjective SDS scores and HRV-based objective logit scores (gray 
areas). Moreover, the HRV-based screening method reduced 
both false negative and false positive error rate, comparing to 
the SDS method.
DiscUssiOn
We proposed an objective, non-invasive, HRV-based screening 
method for clinical risk stratification of patients with MDD using 
LRA. This method performed better than a subjective patient-
reported screening method to discriminate patients with MDD. 
Existing diagnosis methods rely solely on the psychiatric clini-
cian’s impression of the clinical presentation, which has minimal 
objectivity (23). A recent review reported that the accuracy of 
patient-reported and symptom-based diagnosis of MDD was 
approximately 47% (24). In this study, we obtained a similar result 
using patient-reported subjective SDS scores only. In contrast, 
our HRV-based objective method significantly improved screen-
ing accuracy.
Heart rate variability, which is a biomarker that reflects 
alterations in autonomic reactivity, is related to disturbed 
6Sun et al. An Objective MDD Screening Method
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arousal function and can be used as a diagnostic measure and in 
clinical evaluation. In our previous studies, individual HRV and 
HR were shown to vary between depressed and non-depressed 
subjects (17, 18). However, there were significant data overlap 
between the two groups. The need to differentiate between 
patients with MDD and healthy control subjects led to the 
present study, which combined information from individual 
HRV and HR variables in LRA to improve screening accuracy 
in an automated way. The logit score output of this LRA can help 
psychiatric clinicians to make better diagnostic judgments. The 
logit score of the LRA can also be used to evaluate the severity 
of depression, and thereby aid the clinical risk stratification of 
patients with MDD.
The main limitation of this study was that our HRV dataset 
contains a total of 91 subjects, which is small compared to 
typical datasets from the field of classification of medical data 
and information. This is a limiting factor to the accuracy of 
FigUre 5 | heart rate variability (hrV) and heart rate (hr) indices 
before, during, and after a mental task (MT) were compared within 
the MDD and healthy groups. (a) HR of before MT differed significantly 
among MDD and healthy groups (p < 0.05), whereas no significant difference 
are found on MT and after MT conditions. (B) HF of before MT and after MT 
conditions differed significantly among MDD and healthy groups (p < 0.05), 
but no difference was present on MT conditions. (c)  LF/HF of before MT 
and after MT conditions differed significantly among MDD and healthy groups 
(p < 0.05), but no difference on MT conditions.
TaBle 1 | Objective logit scores based on heart rate variability (hrV) 
compared with patient-reported subjective self-rating depression scale 
(sDs) scores.
Diagnosis Objective  
screening (logit  
score ≥0.28)
subjective 
screening  
(sDs score ≥50)
age 
(years)
sex
MDD 2.7 62 40 Male
MDD 2.2 42 (false negative) 50 Male
MDD 1.7 51 40 Male
MDD 1.3 47 (false negative) 24 Male
MDD 0.8 56 49 Male
MDD 0.8 65 51 Male
MDD 0.7 58 59 Female
MDD 0.3 59 52 Female
MDD −1.1 (false negative) 43 (false negative) 65 Female
Healthy 0.7 (false positive) 50 (false positive) 33 Female
Healthy 0.5 (false positive) 57 (false positive) 32 Female
Healthy 0.4 (false positive) 51 (false positive) 35 Female
Healthy 0.2 48 21 Male
Healthy −3.1 38 40 Male
Healthy −3.3 32 27 Female
Healthy −4.6 45 31 Female
Healthy −5.2 33 30 Female
Healthy −8.4 50 (false positive) 30 Female
Healthy −15.3 48 25 Female
Healthy −15.6 56 (false positive) 40 Female
our proposed MDD screening method. In statistical view-
point, the dichotomization may result in the lost of informa-
tion, so the performance to detect the relation between the 
variables and output will also be limited (25). However, in 
this study from the clinical viewpoint, dichotomization may 
be preferred because which offers a simple risk classification 
in setting screening criteria. In order to address these limita-
tions, we plan to extend the current study to include a larger 
sample of clinical data for creating a more accurate logistic 
regression-based discriminant function. It is also important in 
the future study to apply the regression coefficients in the LRA 
on the present dataset to the data from newly recruited control 
subjects and patients with depression in order to consolidate 
the findings.
In addition, the MT paradigm is a provocative procedure 
used to differentiate between MDD and healthy subjects. The 
subject generates his or her own numbers in a random way for 
100 s. This subject-generated method is a limitation that might 
create unintended subject-to-subject variability based on indi-
vidual motivation, cooperation, and perhaps even current mood 
state. Therefore, further research should be done to investigate 
the subject-to-subject variation in this MT and apply other 
biomarkers, such as functional near-infrared spectroscopy, to 
measure the brain activity during subject generating random 
numbers. Moreover, in this study, we measured HRV and HR 
indices via ECG that requires electrodes to be attached to 
patients and can cause discomfort. We will expand this screen-
ing method to incorporate less invasive methods for HRV 
measurement, such as photoplethysmogram, microwave radar, 
or smart phone monitoring (26–28). These bio-measurement 
technologies, which can be combined with our proposed screen-
ing method without the need for electrode placement, allow 
7Sun et al. An Objective MDD Screening Method
Frontiers in Psychiatry | www.frontiersin.org November 2016 | Volume 7 | Article 180
for fully unconstrained HRV measurements to rapidly screen 
patients with MDD.
cOnclUsiOn
In summary, the objective, non-invasive, HRV-based screening 
method developed in this study is effective in discriminating 
patients with MDD, which enables a higher screening sensitivity of 
80.0% compared to the conventional subjective patient-reported 
screening method. Overall, the proposed method, which is based 
on a comprehensive analysis of HRV indices, has high potential 
for use as a novel objective tool in screening patients with MDD.
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